SEI Investments’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$531K Buy
28,117
+16,281
+138% +$276K ﹤0.01% 2630
2025
Q4
$158K Buy
11,836
+1,421
+14% +$17.6K ﹤0.01% 2955
2025
Q3
$123K Hold
10,415
﹤0.01% 2692
2025
Q2
$67.6K Hold
10,415
﹤0.01% 2729
2025
Q1
$60.9K Hold
10,415
﹤0.01% 2665
2024
Q4
$72.5K Hold
10,415
﹤0.01% 2626
2024
Q3
$59.3K Buy
+10,415
New +$72.4K ﹤0.01% 2620

Other funds holding DFTX

SEI Investments's DFTX Position: Q1 2026 in Review

SEI Investments increased its Definium Therapeutics (DFTX) stake by 138% in Q1 2026, buying an estimated $276K and bringing the position to 28,117 shares worth $531K. The position accounts for ﹤0.01% of the portfolio, ranked #2630.

SEI Investments first reported a position in DFTX in Q3 2024 and has held it in 7 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • SEI Investments held 28,117 shares of Definium Therapeutics worth $531K as of Q1 2026.
  • SEI Investments bought 16,281 Definium Therapeutics shares in Q1 2026, an estimated $276K.
  • Definium Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2630 holding.
  • SEI Investments first reported a position in Definium Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.